[ Price : $8.95]
FDA approves emergency use of the BioCryst IV investigational antiviral peramivir in hospitalized adult and pediatric patients wit...[ Price : $8.95]
FDA rejects a Government Accounting Office recommendation that it clarify the conditions that would lead it to exercise regulatory...[ Price : $8.95]
Federal Register Notice: FDA releases a guidance on clinical investigator responsibilities and protecting the rights, safety, and ...[ Price : $8.95]
Federal Register Notice: FDAs Anti-Infective Drugs Advisory Committee will meet 12/9 to discuss developing antibacterial products ...[ Price : $8.95]
An internal FDA review affirms its previous decision to award Shire five years New Chemical Entity (NCE) exclusivity to Vyvanse (l...[ Price : $8.95]
FDA issues a guidance on the role of clinical investigators in conducting trials and protecting subjects rights, safety, and welfa...